European Archives - Page 131 of 1472 - European Medical Journal

Novel Antibiotic Provides Symptom Relief in Uncomplicated UTI

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated urinary tract infection.

Blood Inflammation Ratio Tied to Diabetic Nephropathy

Meta-analysis shows neutrophil to lymphocyte ratio is associated with higher risk and progression of diabetic nephropathy, supporting its potential use as an inflammatory biomarker in clinical practice.

Biologic Persistence Varies by Prior Exposure in Psoriasis Treatment

Real-world Danish registry data show that biologic drug survival in psoriasis differs between biologic-naive and bioexperienced patients.

Global Perspectives on Cystic Fibrosis: Translating Science into Practice

In this series, host Saranya Ravindran speaks with Stuart Elborn about translating science into practice. They explore pivotal CF trials, novel and…

Fast Five: Caroline Michie on Breast Cancer Updates

In this episode, Caroline Michie discusses key data from ASCENT-3, TROPION2, and PLANeT, and how these findings translate into real-world clinical practice and future decision-making.

UK Trial to Screen 42,000 Patients for Early Liver Disease

A major UK trial launched to screen up to 42,000 adults in primary care for early liver disease using non-invasive testing.

What Shapes Vaccination Decisions in Inflammatory Rheumatic Disease?

A qualitative study reveals how trust, communication, and clear responsibility between doctors influence vaccination uptake in patients with inflammatory rheumatic and musculoskeletal diseases.

Cardiovascular Risk Scores Predict Future Eye Health

Higher cardiovascular risk may signal increased likelihood of eye disease. Find out more about protecting long-term eye health.

Rare Peri-Orgasmic Symptoms Are Within Normal Range in Women

A new study found that rare emotional and physical symptoms occurring during orgasm are uncommon but fall within the normal range for women.

breast cancer

BAZ2B Loss Drives Aggressive Breast Cancer Behaviour

Using large public datasets including TCGA, GEO and GTEx, researchers found that BAZ2B expression was consistently reduced in several cancer types, with particularly marked downregulation in breast cancer.